Tapewire

Nasdaq · USD

UTHR

UNITED THERAPEUTICS Corp

Export transactions ↓
Tapewire entity
664
SEC CIK
0001082554
Parsed reports
1,261

Last 12 months

Inside the activity.

1 purchase rows · 2632 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250142
Dec 20250143
Jan 2026078
Feb 2026026
Mar 20260364
Apr 20260346
May 20261340
Jun 20260298
Jul 20260240
Aug 20260251
Sep 20260260
Oct 20260144

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 18, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 154 $235.91 $36,330.14
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 18, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 6,627 $235.05 $1,557,657.13
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $234.73 to $235.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 18, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 5,574 $234.31 $1,306,052.30
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,911

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $233.72 to $234.685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 18, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,037 $233.08 $241,705.20
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,485

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $232.71 to $233.685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 18, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 659 $232.13 $152,976.57
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,522

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $231.605 to $232.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 18, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 949 $230.59 $218,830.76
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,181

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $230.48 to $230.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 18, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · derivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 581,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 597 $238.68 $142,494.59
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $238.315 to $238.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 5,789 $237.58 $1,375,324.57
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 727

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $237.245 to $238.225. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,449 $236.77 $1,053,372.82
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,516

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $236.23 to $237.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,165 $235.63 $981,403.12
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,965

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $235.22 to $236.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-008529 · form4-03192024_040301.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · derivative · entry 17

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 596,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 158 $241.41 $38,142.92
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F14 · price: This transaction was executed in multiple trades at prices ranging from $241.29 to $241.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,267 $240.47 $304,678.78
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 288

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F13 · price: This transaction was executed in multiple trades at prices ranging from $239.225 to $240.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,098 $238.49 $738,851.31
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,555

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F12 · price: This transaction was executed in multiple trades at prices ranging from $238.16 to $239.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 5,955 $237.62 $1,415,019.36
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,653

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F11 · price: This transaction was executed in multiple trades at prices ranging from $237.145 to $238.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,522 $236.74 $1,070,550.94
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,608

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $236.14 to $237.135. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 14, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · derivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 611,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 205 $248.42 $50,926.06
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $248.05 to $248.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 351 $247.19 $86,762.74
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 335

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $246.845 to $247.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,195 $246.17 $294,170.28
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 686

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $245.735 to $246.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 192 $244.90 $47,019.90
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,881

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $244.65 to $245.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,581 $243.63 $872,434.73
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,073

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $243.24 to $244.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,645 $242.60 $884,287.21
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,654

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $242.20 to $243.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,127 $241.61 $755,513.53
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,299

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $241.13 to $242.115. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,704 $240.69 $650,834.68
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,426

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $240.13 to $241.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2024 Filed Mar 15, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-008109 · form4-03152024_040303.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · derivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 626,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 772 $249.82 $192,863.43
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F11 · price: This transaction was executed in multiple trades at prices ranging from $249.72 to $250.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,694 $249.15 $671,203.37
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 902

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $248.69 to $249.675. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,443 $248.09 $1,102,274.98
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,596

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $247.69 to $248.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 7,091 $247.20 $1,752,905.13
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,039

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $246.66 to $247.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC Exercise / conversionStock Options · Derivative 5,000 $0.00 Strike: $175.43 $0.00
Disclosure

SEC source: 0001415889-24-007815 · form4-03132024_040304.xml · derivative · entry 5

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 5,000 shares

Expires 2025-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC SaleCommon Stock 1,750 $248.90 $435,577.98
Disclosure

SEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 4

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,305

F3 · price: This transaction was executed in multiple trades at prices ranging from $248.69 to $248.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC SaleCommon Stock 2,500 $248.03 $620,069.50
Disclosure

SEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 3

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,055

F2 · price: This transaction was executed in multiple trades at prices ranging from $247.61 to $248.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC SaleCommon Stock 750 $247.15 $185,358.90
Disclosure

SEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 2

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,555

F1 · price: This transaction was executed in multiple trades at prices ranging from $246.60 to $247.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC Exercise / conversionCommon Stock 5,000 $175.43 $877,150.00
Disclosure

SEC source: 0001415889-24-007815 · form4-03132024_040304.xml · nonDerivative · entry 1

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,305

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2024 Filed Mar 12, 2024 20:30 UTC Exercise / conversionShare Tracking Award · Derivative 5,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-24-007632 · form4-03122024_040301.xml · derivative · entry 3

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 11, 2024 Filed Mar 12, 2024 20:30 UTC Disposition to issuerCommon Stock 5,000 $249.51 $1,247,550.00
Disclosure

SEC source: 0001415889-24-007632 · form4-03122024_040301.xml · nonDerivative · entry 2

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,480

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 11, 2024 Filed Mar 12, 2024 20:30 UTC Exercise / conversionCommon Stock 5,000 $88.03 $440,150.00
Disclosure

SEC source: 0001415889-24-007632 · form4-03122024_040301.xml · nonDerivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · derivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 641,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,580 $249.76 $1,143,887.98
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $249.465 to $250.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,079 $249.05 $517,767.26
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,710

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $248.46 to $249.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,404 $247.99 $596,163.39
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,789

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $247.46 to $248.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,531 $246.91 $871,829.68
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,193

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $246.425 to $247.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,137 $246.05 $279,761.58
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,724

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $245.385 to $246.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.